Monte Rosa Therapeutics, Inc. (GLUE)

16.31 -0.25 (-1.51%) USD  |  NASDAQ  |  Dec 12, 16:00
16.32 0.00 (0.00%) After-Hours: 20:00
More

Monte Rosa Therapeutics Total Long Term Debt (Quarterly): 35.93M for Sept. 30, 2025

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Novartis AG 24.50B
AVITA Medical, Inc. 44.77M
NanoVibronix, Inc. 0.015M
Mirum Pharmaceuticals, Inc. 316.73M
Day One Biopharmaceuticals, Inc. 2.732M